bioMérieux Future Growth
Future criteria checks 2/6
bioMérieux is forecast to grow earnings and revenue by 14.3% and 7.2% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 12.7% in 3 years.
Key information
14.3%
Earnings growth rate
14.2%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 7.2% |
Future return on equity | 12.7% |
Analyst coverage | Good |
Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,561 | 612 | 507 | 902 | 8 |
12/31/2025 | 4,192 | 527 | 415 | 800 | 11 |
12/31/2024 | 3,901 | 467 | 491 | 800 | 11 |
12/31/2023 | 3,675 | 358 | 107 | 445 | N/A |
9/30/2023 | 3,688 | 372 | 140 | 459 | N/A |
6/30/2023 | 3,701 | 386 | 172 | 472 | N/A |
3/31/2023 | 3,645 | 419 | 180 | 474 | N/A |
12/31/2022 | 3,589 | 452 | 188 | 475 | N/A |
9/30/2022 | 3,525 | 502 | 297 | 583 | N/A |
6/30/2022 | 3,460 | 552 | 406 | 690 | N/A |
3/31/2022 | 3,418 | 577 | 470 | 757 | N/A |
12/31/2021 | 3,376 | 601 | 535 | 825 | N/A |
9/30/2021 | 3,296 | 555 | 424 | 716 | N/A |
6/30/2021 | 3,216 | 509 | 314 | 608 | N/A |
3/31/2021 | 3,167 | 457 | 310 | 595 | N/A |
12/31/2020 | 3,118 | 404 | 305 | 583 | N/A |
9/30/2020 | 2,997 | 355 | 261 | 538 | N/A |
6/30/2020 | 2,876 | 305 | 217 | 493 | N/A |
3/31/2020 | 2,775 | 289 | 176 | 451 | N/A |
12/31/2019 | 2,675 | 273 | 135 | 408 | N/A |
9/30/2019 | 2,601 | 268 | 160 | 419 | N/A |
6/30/2019 | 2,527 | 263 | 185 | 431 | N/A |
3/31/2019 | 2,474 | 260 | 179 | 415 | N/A |
12/31/2018 | 2,421 | 257 | 173 | 400 | N/A |
9/30/2018 | 2,372 | 264 | 162 | 370 | N/A |
6/30/2018 | 2,323 | 271 | 150 | 340 | N/A |
3/31/2018 | 2,306 | 255 | 154 | 341 | N/A |
12/31/2017 | 2,288 | 238 | 158 | 341 | N/A |
9/30/2017 | 2,262 | 216 | N/A | 340 | N/A |
6/30/2017 | 2,237 | 195 | N/A | 339 | N/A |
3/31/2017 | 2,170 | 187 | N/A | 337 | N/A |
12/31/2016 | 2,103 | 179 | N/A | 336 | N/A |
9/30/2016 | 2,068 | 158 | N/A | 339 | N/A |
6/30/2016 | 2,032 | 137 | N/A | 342 | N/A |
3/31/2016 | 1,998 | 124 | N/A | 326 | N/A |
12/31/2015 | 1,965 | 111 | N/A | 310 | N/A |
9/30/2015 | 1,908 | 127 | N/A | N/A | N/A |
6/30/2015 | 1,851 | 144 | N/A | 301 | N/A |
3/31/2015 | 1,775 | 140 | N/A | 300 | N/A |
12/31/2014 | 1,698 | 135 | N/A | 298 | N/A |
9/30/2014 | 1,656 | 135 | N/A | N/A | N/A |
6/30/2014 | 1,614 | 135 | N/A | 246 | N/A |
3/31/2014 | 1,601 | 150 | N/A | 243 | N/A |
12/31/2013 | 1,588 | 164 | N/A | 241 | N/A |
9/30/2013 | 1,581 | 150 | N/A | 240 | N/A |
6/30/2013 | 1,574 | 135 | N/A | 239 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EYWN's forecast earnings growth (14.3% per year) is above the savings rate (0.7%).
Earnings vs Market: EYWN's earnings (14.3% per year) are forecast to grow slower than the German market (15.9% per year).
High Growth Earnings: EYWN's earnings are forecast to grow, but not significantly.
Revenue vs Market: EYWN's revenue (7.2% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: EYWN's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EYWN's Return on Equity is forecast to be low in 3 years time (12.7%).